Alphamab Oncology

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG0330A1013
  • HKG: 9966
HKD
8.56
0.33 (4.01%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAlphamab Oncology VS Pharmaceuticals & Biotechnology
 
1D
4.01%
-1.01%
1W
1.42%
0.49%
1M
16.62%
-4.52%
YTD
144.57%
-3.11%
1Y
200.35%
-5.07%
3Y
0.94%
37.53%
5Y
-53.63%
1.32%
10Y
-53.63%
4.85%
  • Stock Absolute Returns
  • Hang Seng Hong KongAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
72.93%
0%
72.93%
6 Months
128.27%
0%
128.27%
1 Year
200.35%
0%
200.35%
2 Years
12.48%
0%
12.48%
3 Years
0.94%
0%
0.94%
4 Years
-59.04%
0%
-59.04%
5 Years
-53.63%
0%
-53.63%

Alphamab Oncology for the last several years.

stock-summaryRisk Adjusted Returns v/s Hang Seng Hong Kong
Footer loading